Brukinsa Interactions
There are 527 drugs known to interact with Brukinsa (zanubrutinib), along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 231 are major, 293 are moderate, and 3 are minor.
- View all 527 medications that may interact with Brukinsa
- View Brukinsa alcohol/food interactions (2)
- View Brukinsa disease interactions (6)
Most frequently checked interactions
View interaction reports for Brukinsa (zanubrutinib) and the medicines listed below.
- acyclovir
- albuterol
- allopurinol
- amlodipine
- amoxicillin
- atorvastatin
- biotin
- Eliquis (apixaban)
- famotidine
- finasteride
- folic acid
- furosemide
- gabapentin
- Jardiance (empagliflozin)
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- metformin
- metoprolol
- omeprazole
- pantoprazole
- prednisone
- rosuvastatin
- tamsulosin
- tramadol
- Tylenol (acetaminophen)
- valacyclovir
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Brukinsa alcohol/food interactions
There are 2 alcohol/food interactions with Brukinsa (zanubrutinib).
Brukinsa disease interactions
There are 6 disease interactions with Brukinsa (zanubrutinib) which include:
More about Brukinsa (zanubrutinib)
- Brukinsa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (41)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Zanubrutinib
Zanubrutinib is a targeted treatment that may be used to treat adults with chronic lymphocytic ...
Pirtobrutinib
Pirtobrutinib is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes Pirtobrutinib ...
Acalabrutinib
Acalabrutinib (Calquence) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.